We further reveal a role for CD36 as a major contributor to VAT-mediated Kir2.1 and endothelial dysfunction, suggesting that CD36 offers a potential target for preventing the early development of obesity-associated cardiovascular disease. Here, KCNJ2 is linked to obesity due to melanocortin 4 receptor deficiency.